PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. Financials - Benzinga

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc.

PBLAOTCEM

Trade with Public

Trade with Public

$0.00020

-1.11-99.98%

At close: Mar 15, 5:00 PM EST

$0.00020

-1.11-99.98%

After Hours: Mar 16, 4:56 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. Financials

PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (PBLA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Panbela Therapeutics Q3 EPS $(1.48) Up From $(53.74) YoY

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(1.48) per share. This is a 97.25 percent increase over losses of $(53.74) per share from the same period last year.

Benzinga Newsdesk

PRO
Panbela Therapeutics Q1 2024 GAAP EPS $(2.28) Misses $(1.48) Estimate

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(2.28) per share which missed the analyst consensus estimate of $(1.48) by 54.05 percent.

Benzinga Newsdesk

Recap: Panbela Therapeutics Q4 Earnings

Benzinga Insights

PRO
Panbela Therapeutics Q4 2023 GAAP EPS $(65.90) Misses $(24.34) Estimate

Panbela Therapeutics (NASDAQ:PBLA) reported quarterly losses of $(65.90) per share which missed the analyst consensus estimate of $(24.34) by 170.75 percent.

Benzinga Newsdesk

Earnings Preview: Panbela Therapeutics

Benzinga Insights

Crude Oil Down Over 1%; Science 37 Holdings Shares Spike Higher

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 75 points on Monday. The Dow traded up 0.03% to 38,121.11 while the NASDAQ rose 0.48% to 15,529.84. The S&P 500 also rose, gaining, 0.19% to 4,900.27.

Avi Kapoor